223 related articles for article (PubMed ID: 8024230)
1. [Role of hormone replacement therapy during menopause in the cardiovascular prevention].
Turpin G
Ann Cardiol Angeiol (Paris); 1994 Mar; 43(3):177-80. PubMed ID: 8024230
[TBL] [Abstract][Full Text] [Related]
2. Comparative cardiovascular effects of different progestins in menopause.
Rosano GM; Fini M
Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
[TBL] [Abstract][Full Text] [Related]
3. [The effects of hormone replacement therapy (HRT) on lipid metabolism in the menopause].
Camilli A; Di Benedetto L; Camilli FM; Ermini M
Minerva Ginecol; 1997 May; 49(5):199-202. PubMed ID: 9304079
[TBL] [Abstract][Full Text] [Related]
4. Effect of oral and transdermal hormone replacement therapy on lipid profile and Lp(a) level in menopausal women with hypercholesterolemia.
Perrone G; Stefanutti C; Galoppi P; Anelli G; Capri O; Lucani G; Vivenzio A; Mazzarella B; Zichella L
Int J Fertil Menopausal Stud; 1996; 41(6):509-15. PubMed ID: 9010744
[TBL] [Abstract][Full Text] [Related]
5. Cardioprotection by estrogens: mechanisms of action--the lipids.
Samsioe G
Int J Fertil Menopausal Stud; 1994; 39 Suppl 1():43-9. PubMed ID: 8199640
[TBL] [Abstract][Full Text] [Related]
6. KEEPS: The Kronos Early Estrogen Prevention Study.
Harman SM; Brinton EA; Cedars M; Lobo R; Manson JE; Merriam GR; Miller VM; Naftolin F; Santoro N
Climacteric; 2005 Mar; 8(1):3-12. PubMed ID: 15804727
[TBL] [Abstract][Full Text] [Related]
7. [Hormone replacement therapy and cardiovascular risk].
Maffei S; De Caterina R
G Ital Cardiol; 1996 Aug; 26(8):899-940. PubMed ID: 9005173
[TBL] [Abstract][Full Text] [Related]
8. [Hormone substitution in the menopause: effect on lipids and cardiovascular risk].
Keller U
Schweiz Rundsch Med Prax; 1991 Apr; 80(16):413-7. PubMed ID: 2038637
[TBL] [Abstract][Full Text] [Related]
9. [Effects of tamoxifen and estrogen replacement therapy on lipid metabolism and some other cardiovascular risk factors. A prospective study in hysterectomised women].
Imperato F; Marziani R; Perniola G; Ebano V; Fruscella M; Mossa B
Minerva Ginecol; 2003 Feb; 55(1):87-93. PubMed ID: 12598849
[TBL] [Abstract][Full Text] [Related]
10. Oestrogens and the heart.
Rosano GM; Panina G
Therapie; 1999; 54(3):381-5. PubMed ID: 10500455
[TBL] [Abstract][Full Text] [Related]
11. Comparison of effects of continuous combined transdermal with oral estrogen and oral progestogen replacement therapies on serum lipoproteins and compliance.
Erenus M; Karakoç B; Gürler A
Climacteric; 2001 Sep; 4(3):228-34. PubMed ID: 11588947
[TBL] [Abstract][Full Text] [Related]
12. HRT dosing regimens: continuous versus cyclic-pros and cons.
Shoupe D
Int J Fertil Womens Med; 2001; 46(1):7-15. PubMed ID: 11294619
[TBL] [Abstract][Full Text] [Related]
13. [Menopause and hormone replacement therapy].
Tóth KS
Orv Hetil; 2000 Mar; 141(11):547-56. PubMed ID: 10741167
[TBL] [Abstract][Full Text] [Related]
14. Effect of hormone replacement therapy on lipoprotein(a) and lipid levels in postmenopausal women. Influence of various progestogens and duration of therapy.
Kim CJ; Min YK; Ryu WS; Kwak JW; Ryoo UH
Arch Intern Med; 1996 Aug 12-26; 156(15):1693-700. PubMed ID: 8694668
[TBL] [Abstract][Full Text] [Related]
15. Impact of menopause on lipid and bone metabolism and effect of hormone replacement therapy.
Murano T; Izumi S; Kika G; Haque SF; Okuwaki S; Mori A; Suzuki T; Matsubayashi H; Ikeda M; Goya K; Makino T
Tokai J Exp Clin Med; 2003 Oct; 28(3):109-19. PubMed ID: 15055403
[TBL] [Abstract][Full Text] [Related]
16. [Prevention of cardiovascular risk in menopause women: role of ovarian hormones].
Rosano GM; Leonardo F; Ricci S; Serra GB; Chierchia SL
Ann Ist Super Sanita; 1997; 33(2):199-202. PubMed ID: 9470240
[TBL] [Abstract][Full Text] [Related]
17. The effect of hormone replacement therapy on the levels of serum lipids, apolipoprotein AI, apolipoprotein B and lipoprotein (a) in Turkish postmenopausal women.
Bayrak A; Aldemir DA; Bayrak T; Corakçi A; Dursun P
Arch Gynecol Obstet; 2006 Aug; 274(5):289-96. PubMed ID: 16810536
[TBL] [Abstract][Full Text] [Related]
18. Effects of conjugated equine estrogens or raloxifene on lipid profile, coagulation and fibrinolysis factors in postmenopausal women.
Dias AR; Melo RN; Gebara OC; D'Amico EA; Nussbacher A; Halbe HW; Pinotti JA
Climacteric; 2005 Mar; 8(1):63-70. PubMed ID: 15804733
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin-converting enzyme gene polymorphism, lipids, and apolipoproteins in menopausal women on hormone replacement therapy.
Cubrilo-Turek M; Sertić J; Duraković Z
Acta Med Croatica; 2001; 55(4-5):161-7. PubMed ID: 12398019
[TBL] [Abstract][Full Text] [Related]
20. Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteins.
Vrablik M; Fait T; Kovar J; Poledne R; Ceska R
Metabolism; 2008 Aug; 57(8):1088-92. PubMed ID: 18640386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
